Clare Matschullat, Founder and CEO at Clare the Cancer Sherpa Inc, shared OncoDaily Newsletter’s post on LinkedIn, adding:
“If you work in cancer, even peripherally, it is important to watch what drugs and therapeutics are in the pipeline. Often these will become the standard of care, but can be used to treat patients grant compassionate use long before that!
You can also read: 10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
